Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Coty's earnings call reveals mixed signals. While there are positive indicators like growth in skincare and prestige fragrance revenue, and a focus on deleveraging, there are notable challenges. These include retailer inventory reduction, tariff impacts, and macroeconomic volatility. The lack of precise guidance due to high volatility adds uncertainty. Additionally, while EBITDA is expected above $1 billion, it is heavily impacted by tariffs. The absence of a shareholder return plan discussion further tempers enthusiasm. Overall, the combination of positive and negative factors suggests a neutral stock price movement in the near term.
EBITDA EBITDA for the full year is expected to be above $1 billion. The major gap in EBITDA for the full year is driven by tariffs. Excluding tariffs, EBITDA would be slightly negative. The company is implementing productivity actions and cost savings to mitigate the impact of tariffs.
Free Cash Flow Free cash flow is expected to grow in fiscal '26. This is supported by actions to improve inventory management, forecasting tools, and cost discipline.
Mass Fragrance Revenue Mass fragrance revenue accounts for approximately 7% of net revenues and is growing nicely. The market is growing globally, driven by the 'treatonomics' phenomenon, where fragrances at all price points are becoming popular. The profitability of this category is comparable to fragrance launches.
Skin Care Growth Lancaster, a key skin care brand, is growing strongly in China, outperforming the market by 11%. The growth is driven by e-commerce, with Lancaster growing 40% faster than the Chinese ecosystem market.
Prestige Fragrance Market The Prestige fragrance market is growing, with niche fragrances above $150 growing by 14% and fragrances under $50 growing by 11%. The company is leveraging this trend with innovative products like perfume mists and pen sprays.
Inventory Management Retailers' inventory reduction is expected to last until the end of calendar year '25. The company is implementing forecasting tools and strategic revenue management to improve inventory levels and reduce excess.
HUGO BOSS Beyond bottle: Starting as the biggest launch in the company's history, surpassing previous launches like Glade.
Perfume plan: Includes almost a dozen brands with innovative formulations, representing a significant addition to the company's product pipeline.
Fragrance mists: Launched as a modern eau de cologne, targeting younger consumers with affordability and profitability.
Mass fragrance growth: Mass fragrances now represent 7% of net revenues, growing nicely and diversifying consumer options.
Travel retail: Sales in travel retail Americas and EMEA are growing, with a focus on making travel retail a discovery channel for new products.
China market: Lancaster brand is growing strongly in China, outperforming the skincare market by 11%.
Inventory management: Retailers' inventory reduction expected to last until the end of calendar year 2025, with sequential improvement in Q1 and Q2 of fiscal 2026.
Cost-saving initiatives: Productivity actions and the All-in to Win plan are expected to bring savings in the second half of fiscal 2026.
Media investment: Increased media spending to support brand icons and innovations.
Focus on scenting: Positioning the company to own the full spectrum of scenting products from $5 to $500, including fragrances and mists.
Consumer Beauty profitability: Prioritizing profitability over revenue growth in the Consumer Beauty segment, with a focus on loyal consumers and ROI-driven investments.
Wella stake divestiture: Commitment to divest the Wella stake to support deleveraging and financial health.
Retailer Inventory Reduction: The company is facing a phase of retailer inventory reduction, which is expected to last until the end of calendar year 2025. This creates a headwind for sales and impacts the alignment of sell-in and sell-out.
Tariff Impact: Tariffs are a significant headwind, particularly impacting EBITDA. The company estimates a $50-$55 million net headwind from tariffs, which is affecting gross margins and overall profitability.
High Volatility in H2 Projections: The company has not provided precise numbers for the second half of fiscal 2026 due to high macroeconomic volatility, creating uncertainty in forecasting.
Promotional Environment: There is an increase in promotional activities from competitors and retailers, particularly in the U.S. This creates pressure on pricing and profitability, especially in the Prestige and Consumer Beauty segments.
Innovation Fatigue in Color Cosmetics: The color cosmetics market is experiencing innovation fatigue and simplification of routines, leading to a slowdown in consumer engagement and sales.
Reseller Shrinkage in Asia: The Prestige segment is facing challenges in Asia due to a decline in reseller activity, particularly in the Hainan, China, and Korea ecosystems.
Travel Retail Weakness in Asia: The travel retail channel in Asia remains weak, heavily linked to Chinese consumption, which has not fully recovered.
Economic Pressures on Retailers: Retailers are under pressure to manage working capital, leading to cautious inventory management and contributing to the destocking trend.
Currency Exchange Impact: The euro-dollar exchange rate is negatively impacting gross margins, particularly due to sourcing in Europe for the U.S. market.
Consumer Beauty Profitability Challenges: The Consumer Beauty segment is generating insufficient profit, requiring significant cost and operational adjustments to improve margins.
Revenue and EBITDA Projections: Coty expects sequential improvement in Q1 and Q2 of fiscal 2026, despite ongoing retailer inventory reductions. The company anticipates returning to growth in H2 fiscal 2026, supported by strong innovations and market recovery. Full-year EBITDA is projected to exceed $1 billion, with positive EBITDA growth in H2.
Retailer Inventory and Market Trends: Retailer inventory reductions are expected to persist until the end of calendar year 2025, with normalization anticipated in calendar year 2026. The prestige and mass fragrance categories remain healthy, with low to mid-single-digit growth.
Product Launches and Innovations: Coty plans significant product launches, including the HUGO BOSS Beyond bottle and another blockbuster launch in H2 fiscal 2026. The company is also focusing on innovative formulations in its perfume portfolio, which are expected to drive growth.
Free Cash Flow and Cost Management: Free cash flow is expected to grow in fiscal 2026. The company is implementing productivity actions and cost-saving measures, including the All-in to Win plan, to offset tariff impacts and improve margins.
Consumer Beauty and Mass Fragrances: Coty is increasing profitability in the Consumer Beauty segment by optimizing investments and focusing on ROI-driven strategies. The mass fragrance category, representing 7% of net revenues, is growing strongly and is as profitable as prestige fragrances.
Travel Retail and Regional Performance: Travel retail in the Americas and EMEA is growing, while the Asian travel retail market remains affected by Chinese consumption trends. Coty is leveraging travel retail as a discovery channel with exclusive product launches.
Debt Refinancing and Wella Stake Sale: Coty is actively working on refinancing its 2026 debt maturity and remains committed to divesting its Wella stake to support deleveraging and improve financial flexibility.
The selected topic was not discussed during the call.
The earnings call presents a mixed picture: while Coty expects revenue growth in the second half of FY26 and has plans for new product launches and e-commerce expansion, there are concerns over revenue declines in the first half and legal issues with the Gucci license. The Q&A reveals uncertainty in management's responses, particularly regarding the Gucci transition and Consumer Beauty strategic review. These factors, combined with the lack of clear market cap data, suggest a neutral stock price movement over the next two weeks.
Coty's earnings call reveals mixed signals. While there are positive indicators like growth in skincare and prestige fragrance revenue, and a focus on deleveraging, there are notable challenges. These include retailer inventory reduction, tariff impacts, and macroeconomic volatility. The lack of precise guidance due to high volatility adds uncertainty. Additionally, while EBITDA is expected above $1 billion, it is heavily impacted by tariffs. The absence of a shareholder return plan discussion further tempers enthusiasm. Overall, the combination of positive and negative factors suggests a neutral stock price movement in the near term.
The company's strong financial performance, with increased operating income, net income, and EPS, alongside optimistic guidance for fiscal '26, suggests a positive outlook. Despite some challenges, management's confidence in achieving EBITDA above $1 billion and strategic plans for innovation and market expansion support a positive sentiment. The Q&A reveals proactive strategies to address market challenges, and the focus on deleveraging through Wella stake divestiture adds to the positive sentiment. Overall, the positive aspects outweigh the negative, suggesting a 2% to 8% stock price increase.
Despite some positive elements like cost savings and product launches, the overall sentiment is negative due to significant risks such as U.S. market underperformance, inventory destocking, and tariff impacts. These challenges, combined with a projected sales decline and weak guidance, outweigh positive factors like sustainability initiatives and debt improvements. The lack of clear responses in the Q&A section further adds to uncertainties, likely leading to a stock price decline in the coming weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.